Stay updated on FF-10101-01 Study in Relapsed AML Clinical Trial
Sign up to get notified when there's something new on the FF-10101-01 Study in Relapsed AML Clinical Trial page.

Latest updates to the FF-10101-01 Study in Relapsed AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a maintenance update. The visible content and user experience appear unchanged.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, representing a small behind-the-scenes update to the page version.SummaryDifference0.0%

- Check49 days agoChange DetectedThe revision history shows that v3.6.4 was added and the previous v3.6.3 was removed, updating the site's version tag.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 on the page, indicating a minor update to the document version.SummaryDifference0.0%

- Check78 days agoChange DetectedThe page's revision label was updated to v3.6.2, indicating a platform update. The study details and content remain unchanged.SummaryDifference0.0%

- Check92 days agoChange DetectedEnrollment status updated to 'No longer looking for participants,' signaling that recruitment has closed. The page also adds new navigational and help sections, such as How to Read a Study Record and Common Questions, to improve user guidance.SummaryDifference0.4%

Stay in the know with updates to FF-10101-01 Study in Relapsed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FF-10101-01 Study in Relapsed AML Clinical Trial page.